Krel joined Sofinnova Partners as a Senior Associate in 2013 and has been involved in the venture capital firm’s investment activities in industrial biotech since then. He is an observer on the board of Comet Bio and a board member of EnobraQ and Afyren.

Prior to joining Sofinnova Partners, Krel spent six years in industrial biotech start-ups, holding business development positions.  Additionally, he was a consultant focused on R&D strategic and organizational issues. Krel has a graduate degree in engineering from Ecole Polytechnique and holds a PhD in organic chemistry from Paris X Orsay University.

Sofinnova Partners’ Industrial Biotech franchise is dedicated to start-ups with a specific emphasis on synthetic biology, food, feed, agriculture, materials and chemicals, and represents more than 200 M€ under management.